475830 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Orum Therapeutics, Inc. operates as a biotechnology company. It engages in the development of treatments for cancer and immune diseases. The company was founded by Seung-Ju Lee and Yong-Sung Kim on August 17, 2016 and is headquartered in Daejeon, South Korea.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
475830 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company